Learn more about our Diabetes work.
AdvaMed® released a statement in support of the bipartisan PREVENT DIABETES Act, which was marked up today in the House Energy and Commerce Health Subcommittee. The legislation, introduced by Reps. Diana…
Today, diabetes was front and center during a Senate HELP Committee hearing, prompting AdvaMed® President and CEO Scott Whitaker to release the following statement on the ways life-saving medical technology…
Medicare is the single biggest health care insurer in the United States. When Medicare covers products or services, millions of Americans benefit. Unfortunately, because Medicare is so big, the coverage…
Each November,AdvaMed® partners with our member companies to raise awareness and highlight medtech’s role in helping patients manage their diabetes and live fuller and better lives.
Diabetes is a serious health problem in the United States. The consequences of unchecked diabetes are dire. But there’s good news to celebrate during National Diabetes Month and on World…
A new national poll conducted by Morning Consult on behalf of AdvaMed, The Medtech Association®, found that an overwhelming number of Americans believe medical technology plays a significant role in…
The sector dedicated to enhancing the care and treatment of individuals with diabetes using the latest methods and technology.
AdvaMed® submitted a letter regarding proposed local coverage determinations entitled “Skin Substitutes for the Treatment of Diabetic Foot Ulcers and Venous Leg Ulcer.”
November is Diabetes Awareness Month, and Medtech POV was excited to welcome Lisa Earnhardt, who leads many of Abbott’s initiatives addressing this prevalent disease.
Lisa Earnhardt, Executive Vice President, Medical Devices, at Abbott joined AdvaMed®’s Scott Whitaker on the Medtech POV podcast to discuss how innovation and technology are helping patients manage diabetes, allowing…